Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CA.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
CA.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CA.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
CA.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CA.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CA.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CA.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CA.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.9EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BN.1.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.9ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
BN.1.9ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BN.1.9EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BN.1.9EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BN.1.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.28EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.28ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.28ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.28EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.28EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.28ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.28ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DG.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
DG.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DG.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
DG.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
DG.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
DG.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
DG.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DG.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DR.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
DR.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DR.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
DR.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
DR.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
DR.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
DR.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DR.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.27EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.7.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.27ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BF.7.27ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used